New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
Kevin Kunzmann
Advertisement
Articles by Kevin Kunzmann
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis
2
FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy
3
Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults
4
Ruxolitinib Efficacy and Safety in Pediatric AD
5
